Pfizer dives into prevention theme at Emerging Diseaes symposium
Future prevention of emerging swine diseases will be the subject of a special satellite symposium sponsored by Pfizer Animal Health as part of the 6th International Symposium on Emerging and Re-emerging Pig Diseases in Barcelona in June.
The meeting will provide an update on the development of vaccines to prevent some of the diseases that are causing most concern among scientists and veterinarians and which pose the biggest threats to the swine industry. Presentation subjects include vaccine vector development, EC-funded development of a marker vaccine for Classical Swine Fever, prospects for a vaccine against African Swine Fever, PRRSV and PCV2.
Research into diseases
The company, headquartered in New York, USA, has significantly increased its research on emerging diseases in recent years and during the main conference it will present the results of studies in different areas, such as swine influenza, marker CSF vaccine and the assessment and implications of PCV maternally derived antibodies in piglets.
The company, headquartered in New York, USA, has significantly increased its research on emerging diseases in recent years and during the main conference it will present the results of studies in different areas, such as swine influenza, marker CSF vaccine and the assessment and implications of PCV maternally derived antibodies in piglets.
The satellite symposium will be held in the main congress centre on 13 June from 5 pm to 6.30 pm. All delegates are welcome to attend.
Related websites:
Join 18,000+ subscribers
Subscribe to our newsletter to stay updated about all the need-to-know content in the pigsector, three times a week.
